Year archive

3D Medicines Inc. — 2024 filings

All 39 regulatory filings released by 3D Medicines Inc. (1244) in 2024, sourced directly from the official regulator.

39 Filings

2024 Period

2024 filings (39)

Filing	Released	Lang
INSIDE INFORMATION CHANGE IN USE OF PROCEEDS FROM 2023 PLACING Capital/Financing Update	2024-12-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Share Issue/Capital Change	2024-10-04	English
Interim Report 2024 Interim / Quarterly Report	2024-09-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-05	English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY DIRECTOR AND SINGLE LARGEST SHAREHOLDER AND SENIOR MANAGEMENT Director's Dealing	2024-09-04	English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2023 ANNUAL REPORT Regulatory Filings	2024-09-04	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report	2024-08-30	English
DATE OF BOARD MEETING Regulatory Filings	2024-08-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-05	English
ADOPTION OF CHINESE NAME AND CHANGE OF STOCK SHORT NAME Regulatory Filings	2024-07-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Share Issue/Capital Change	2024-07-05	English
Amended and Restated Memorandum and Articles of Association Governance Information	2024-07-03	English
Amended and Restated Memorandum and Articles of Association Governance Information	2024-06-28	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 28, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-28	English
Form of proxy for the Annual General Meeting to be held on Friday, June 28, 2024 AGM Information	2024-06-05	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2024-06-05	English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; CHANGE OF AUDITOR; PROPOSED ADOPTION OF CHINESE NAME; PROPOSED AMENDMENTS TO THE MEMORAND AGM Information	2024-06-05	English
PROPOSED CHANGE OF AUDITOR Regulatory Filings	2024-06-05	English
PROPOSED ADOPTION OF CHINESE NAME CHANGE OF DATE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE PERIOD AGM Information	2024-06-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-02	English
Environmental, Social and Governance Report 2023 Environmental & Social Information	2024-04-28	English
Annual Report 2023 Regulatory Filings	2024-04-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-08	English
GRANT OF SHARE OPTIONS Regulatory Filings	2024-04-05	English
CLARIFICATION ANNOUNCEMENT REGARDING THE ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 Regulatory Filings	2024-04-03	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY Annual Report	2024-03-28	English
DATE OF BOARD MEETING Report Publication Announcement	2024-03-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-01	English
Next Day Disclosure Return Transaction in Own Shares	2024-02-15	English
Next Day Disclosure Return Transaction in Own Shares	2024-02-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-06	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-31	English
VOLUNTARY ANNOUNCEMENT LICENSE AGREEMENT WITH ALPHAMAB AND GLENMARK FOR ENVAFOLIMAB Capital/Financing Update	2024-01-25	English
VOLUNTARY ANNOUNCEMENT REPAYMENT OF SHORT-TERM LOAN BY THE BORROWER Capital/Financing Update	2024-01-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-05	English
CONNECTED TRANSACTION THE LOAN AGREEMENT Capital/Financing Update	2024-01-03	English